Literature DB >> 35690417

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.

Noah A Kaitz1, Cindy L Zuleger2, Peng Yu3, Michael A Newton4, Richard J Albertini5, Mark R Albertini6.   

Abstract

Somatic cell gene mutations arise in vivo due to replication errors during DNA synthesis occurring spontaneously during normal DNA synthesis or as a result of replication on a DNA template damaged by endogenous or exogenous mutagens. In principle, changes in the frequencies of mutant cells in vivo in humans reflect changes in exposures to exogenous or endogenous DNA damaging insults, other factors being equal. It is becoming increasingly evident however, that somatic mutations in humans have a far greater range of interpretations. For example, mutations in lymphocytes provide invaluable probes for in vivo cellular and molecular processes, providing identification of clonal amplifications of these cells in autoimmune and infectious diseases, transplantation recipients, paroxysmal nocturnal hemoglobinuria (PNH), and cancer. The assay for mutations of the X-chromosomal hypoxanthine guanine phosphoribosyltransferase (HPRT) gene has gained popular acceptance for this purpose since viable mutant cells can be recovered for molecular and other analyses. Although the major application of the HPRT T cell assay remains human population monitoring, the enrichment of activated T cells in the mutant fraction in individuals with ongoing immunological processes has demonstrated the utility of surrogate selection, a method that uses somatic mutation as a surrogate marker for the in vivo T cell proliferation that underlies immunological processes to investigate clinical disorders with immunological features. Studies encompassing a wide range of clinical conditions are reviewed. Despite the historical importance of the HPRT mutation system in validating surrogate selection, there are now additional mutational and other methods for identifying immunologically active T cells. These methods are reviewed and provide insights for strategies to extend surrogate selection in future studies.
Copyright © 2022. Published by Elsevier B.V.

Entities:  

Keywords:  Hypoxanthine Guanine Phosphoribosyltransferase gene; Phosphoinositolglycan class A gene; Spontaneous T cell gene mutations; Surrogate selection

Mesh:

Substances:

Year:  2022        PMID: 35690417      PMCID: PMC9188651          DOI: 10.1016/j.mrrev.2022.108414

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   7.015


  151 in total

1.  Counting absolute numbers of molecules using unique molecular identifiers.

Authors:  Teemu Kivioja; Anna Vähärautio; Kasper Karlsson; Martin Bonke; Martin Enge; Sten Linnarsson; Jussi Taipale
Journal:  Nat Methods       Date:  2011-11-20       Impact factor: 28.547

2.  Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.

Authors:  Alena Gros; Maria R Parkhurst; Eric Tran; Anna Pasetto; Paul F Robbins; Sadia Ilyas; Todd D Prickett; Jared J Gartner; Jessica S Crystal; Ilana M Roberts; Kasia Trebska-McGowan; John R Wunderlich; James C Yang; Steven A Rosenberg
Journal:  Nat Med       Date:  2016-02-22       Impact factor: 53.440

3.  Somatic cell mutation. Detection and quantification of x-ray-induced mutation in cultured, diploid human fibroblasts.

Authors:  R J Albertini; R DeMars
Journal:  Mutat Res       Date:  1973-05       Impact factor: 2.433

Review 4.  New insights of T cells in the pathogenesis of psoriasis.

Authors:  Yihua Cai; Chris Fleming; Jun Yan
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

5.  Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus.

Authors:  M T Falta; G K Magin; M Allegretta; L Steinman; M A Atkinson; S W Brostoff; R J Albertini
Journal:  Clin Immunol       Date:  1999-03       Impact factor: 3.969

6.  Increased frequency of mutations in the hprt gene of T cells isolated from patients with anti-U1-70kD-autoantibody-positive connective tissue disease.

Authors:  M M Holyst; D L Hill; G C Sharp; R W Hoffman
Journal:  Int Arch Allergy Immunol       Date:  1994-11       Impact factor: 2.749

7.  Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus.

Authors:  S Theocharis; P P Sfikakis; R N Lipnick; G L Klipple; A D Steinberg; G C Tsokos
Journal:  Clin Immunol Immunopathol       Date:  1995-02

8.  Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis.

Authors:  P A Lodge; M Allegretta; L Steinman; S Sriram
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

9.  Overview of methodologies for T-cell receptor repertoire analysis.

Authors:  Elisa Rosati; C Marie Dowds; Evaggelia Liaskou; Eva Kristine Klemsdal Henriksen; Tom H Karlsen; Andre Franke
Journal:  BMC Biotechnol       Date:  2017-07-10       Impact factor: 2.563

Review 10.  Human de novo purine biosynthesis.

Authors:  Vidhi Pareek; Anthony M Pedley; Stephen J Benkovic
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-11-12       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.